As a Chief Operating Officer (COO) I'm among leading scientific advisors to build a pharmaceutical company on a green field, and oversee various aspects of regulatory compliance, establishment and maintenance of robust pharmaceutical quality management system, operational excellence, strategic planning, leadership and team development, innovation and technology adoption, financial acumen and ethical ans social responsibility. By providing technical expertise with strategic vision and effective leadership, keeping abreast of industry trends, regulatory changes, and technological advancement, ensure competitive and successful pharmaceutical operations of the company. I have over 20 years managerial experience in pharmaceutical industry within Research and Development, Regulatory Affairs and Business Development. Since 2006 my research is focused on lipid nanoparticles as innovative pharmaceutical dosage systems for targeted delivery of active ingredient to specific organ/tissue. I have know-how in development of drug delivery systems for BCS II, IV active ingredients by improving poor dissolution and bioavailability. I also have experience in pharmaceutical product development covering solid dosage forms, semi-solids, liquids and small volume parenterals within different business segments: generic products, food supplements and cosmetic products in a highly regulated GMP environment. Having possibility to work in various international roles within pharmaceutical industry, I gained extensive experience in material science, new process development, technology transfer, stability studies and quality control, bioequivalence studies, quality management, regulatory requirements and commercialization of products derived from research. I am a highly motivated, self-starting person with ability for strategic thinking. I have strong organizational and team leading skills.